Mitsubishi UFJ Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.57K Hold
58
– – ﹤0.01% 1536
2026
Q1
$6.33K Hold
58
– – ﹤0.01% 1464
2025
Q4
$4.65K Hold
58
– – ﹤0.01% 1496
2025
Q3
$5.08K Hold
58
– – ﹤0.01% 1456
2025
Q2
$4.82K Hold
58
– – ﹤0.01% 1468
2025
Q1
$4.87K Hold
58
– – ﹤0.01% 1445
2024
Q4
$5.32K Hold
58
– – ﹤0.01% 1424
2024
Q3
$5.39K Hold
58
– – ﹤0.01% 1396
2024
Q2
$4.77K Hold
58
– – ﹤0.01% 1382
2024
Q1
$3.85K Hold
58
– – ﹤0.01% 1445
2023
Q4
$3.13K Hold
58
– – ﹤0.01% 1509
2023
Q3
$3.16K Buy
+58
New +$3.44K ﹤0.01% 1451

Other funds holding LMAT

Mitsubishi UFJ Asset Management's LMAT Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management held its LeMaitre Vascular (LMAT) position steady in Q2 2026 at 58 shares worth $5.57K. The position accounts for ﹤0.01% of the portfolio, ranked #1536.

Mitsubishi UFJ Asset Management first reported a position in LMAT in Q3 2023 and has held it in 12 quarters since. The position peaked at $6.33K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Mitsubishi UFJ Asset Management held 58 shares of LeMaitre Vascular worth $5.57K as of Q2 2026.
  • Mitsubishi UFJ Asset Management left its LeMaitre Vascular share count unchanged in Q2 2026.
  • LeMaitre Vascular made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #1536 holding.
  • Mitsubishi UFJ Asset Management first reported a position in LeMaitre Vascular in Q3 2023 and has held it in 12 quarters since.
  • Mitsubishi UFJ Asset Management's LeMaitre Vascular position peaked at $6.33K in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.